The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Stryker Corp
XMUN:SYK
|
US |
|
B
|
BCWorldPharm Co Ltd
KOSDAQ:200780
|
KR |
|
B
|
Blackstone Mortgage Trust Inc
F:079A
|
US |
|
Abrau-Durso PAO
MOEX:ABRD
|
RU |
|
EMCOR Group Inc
NYSE:EME
|
US |
|
Orrstown Financial Services Inc
NASDAQ:ORRF
|
US |
|
Dynex Capital Inc
NYSE:DX
|
US |
|
Datagate Bilgisayar Malzemeleri Ticaret AS
IST:DGATE.E
|
TR |
|
C
|
Constellium SE
F:3OK
|
FR |
|
Cambridge Cognition Holdings PLC
F:1M7
|
UK |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
G
|
Giglio.Com SpA
MIL:GCOM
|
IT |
|
S
|
Sumitomo Pharma Co Ltd
F:DPM
|
JP |
|
ENRG Elements Ltd
ASX:BRY
|
AU |
|
M
|
Mitsubishi Estate Co Ltd
DUS:MES
|
JP |
|
M
|
Marie Brizard Wine and Spirits SA
DUS:BED
|
FR |
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
H
|
Honda Motor Co Ltd
SWB:HDMA
|
JP |
|
S
|
SSE PLC
DUS:SCT
|
UK |
|
S
|
Somnigroup International Inc
F:TPD
|
US |
|
Robinhood Markets Inc
NASDAQ:HOOD
|
US |
|
A
|
Astro Resources NL
ASX:ARO
|
AU |
|
T
|
Toll Brothers Inc
XMUN:TLK
|
US |
|
DIAMOND FOOD INDONESIA Tbk PT
IDX:DMND
|
ID |
Stryker Corp (SYK)’s 12-month stock price forecast through October 2027 has a consensus target of €347.41, implying 26% upside. The forecast is based on price targets from 28 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
SYK is 347.41 EUR with a low forecast of 273.37 EUR and a high forecast of 443.46 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 7 years is 8%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 7 years is 9%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 7 years is 13%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 24%.
Over the last 13 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 7 years is 19%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more